Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn’s Disease and a Loss of Response to This Therapy

Autor:	A Bouhmidi, Daniel Bonillo, Saioa de la Maza, Iago Rodríguez-Lago, Manuel Barreiro-de Acosta, Guillermo Bastida, Olga Merino, Laura Jiménez, L Melcarne, Iván Guerra, Beatriz Orts, A López-García, M Vela, Francisco Mesonero, Alicia Algaba, Alicia Granja, Pilar López-Serrano, Marta Carrillo-Palau, Fernando Bermejo
Rok vydání:	2021
Předmět:	medicine.medical_specialty Crohn's disease business.industry Gastroenterology MEDLINE medicine.disease Internal medicine Ustekinumab medicine Immunology and Allergy In patient business medicine.drug
Zdroj:	Inflammatory Bowel Diseases. 28:150-150
ISSN:	1536-4844 1078-0998
DOI:	10.1093/ibd/izab242
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::31eb3cbb811ca91a1985e63c52e3a200 https://doi.org/10.1093/ibd/izab242 Zobrazit plný text záznamu